The Institute of Immunology is the oldest manufacturer of immunobiological medicines in this part of Europe. Since 1893 and our vaccine against small-pox until today’s viral and bacterial vaccines, products from human and equine plasma, allergens and other products, our aim remains the same: PREVENTION AND FIGHTING DISEASE

Let me Introduce a new and modern concept of the websites relying on the great tradition and looking to the future. Here you can learn all about our products, our work of special importance to human health, our visions on research and development. Familiarize yourself with our ownership structure, financial reports and guidelines of further development and goals. ...continuation of the introduction


view all NEWS
09/30/2011
In September 2011. leaders of TRANSVAC, a collaborative infrastructure project funded under the European Commission’s (EC) 7th Framework Programme (FP7), have accepted the application of dr. Jelena Ivančić Jelečki and colleagues from Molecular Biomedicine Unit.
more
09/28/2011
In 2006, a group of researchers and professionals formed a global Alliance for Rabies Control. They created and began inviting partners to join the World Rabies Day initiative.
more

Results

The Institute, with its technology, products and expert personnel can compete in the market for viral vaccines on a global scale and for plasma fractionation on a regional level.

Goals

  • Getting started in new facilities
  • Multiple capacity increase
  • Satisfy GMP requirements

Development

The main goal of our research and development is to develop new biotechnical products with high added value. Our research potential is focused on the development of new vaccines and blood plasma preparations.